Strategic Partnerships Clinigen is actively expanding its ecosystem through minority stake investments and partnerships with Tepsivo, signaling open collaboration with specialized service providers in digital pharmacovigilance. This creates cross-sell opportunities for integrated clinical trial management and PV services.

Global Supply Expertise With over 25 years of clinical supply expertise and a global network for packaging, labeling, storage, distribution, comparator sourcing, and biological sample management, Clinigen can position as a one-stop solution for multi-country trials and complex supply chains.

Exclusive Supply Agreements Recent collaboration with Santhera Pharmaceuticals to manage supply and distribution of a specialized product in non-commercial markets indicates appetite for exclusive or dedicated supply arrangements, offering a pathway to long-term, high-value contracts.

Rare Disease Focus NaviGATE initiative demonstrates Clinigen’s commitment to rare diseases and patient advocacy programs, suggesting opportunities to partner on patient access programs, educational initiatives, and early engagement strategies that complement trial logistics.

Growth via Digital PV strategic move into digital pharmacovigilance through Tepsivo positions Clinigen to offer integrated PV services, enabling expanded service lines for safety management, risk assessment, and post-marketing support to existing and new clients.